OVARIAN CLEAR CELL CARCINOMA
Clinical trials for OVARIAN CLEAR CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CLEAR CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN CLEAR CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Virus therapy may Re-Sensitize ovarian cancer to chemo
Disease control Recruiting nowThis study tests whether a cancer-killing virus (Olvi-Vec) given into the abdomen can make platinum-resistant ovarian cancer respond to chemotherapy again. About 186 women whose cancer has not responded to at least three prior treatments will receive either Olvi-Vec plus chemo an…
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE3 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated May 17, 2026 05:48 UTC
-
New combo therapy aims to tame rare ovarian cancer
Disease control Recruiting nowThis study tests whether combining two drugs, dostarlimab and LB-100, can help control ovarian clear cell carcinoma. About 21 adults with recurrent cancer will receive the treatment. The goal is to see if the combination is safe and shrinks or stabilizes the cancer.
Matched conditions: OVARIAN CLEAR CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 12, 2026 13:42 UTC